Social Media Listening for Real World Evidence

Progress, Insights, and Future Directions

This webinar explores how Social Media Listening (SML) is advancing the generation of real-world evidence (RWE) and supporting more patient-focused drug development.
 
This session will provide:

• An update on the project’s progress, including insights from a recently published research paper.
• An overview of ongoing work to capture patient and caregiver perspectives through a dedicated survey.
• Emerging best practices for the ethical and responsible use of publicly shared online health discussions.
• A discussion of the growing role of artificial intelligence in transforming unstructured social media data into meaningful, actionable evidence, with perspectives from industry leaders. Attendees will gain practical insights into methodological considerations, opportunities for regulatory engagement, and the future potential of AI-enabled patient experience data to complement traditional evidence sources.

This session is ideal for professionals across pharmaceutical R&D, real-world evidence, patient engagement, regulatory science, and digital health who are interested in innovative approaches to incorporating the patient voice into healthcare decision-making.

If you would like to find out more, please contact Aditya Tyagi.